欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号PT/H/0867/001
药品名称Beta-histina Aurobindo
活性成分
    • betahistine hydrochloride 8.0 mg
剂型Tablet
上市许可持有人Aurobindo Pharma (Portugal), Unipessoal Lda.
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Bulgaria (BG)
      Betahistine Aurobindo
    • Netherlands (NL)
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Poland (PL)
    • Cyprus (CY)
      BETAHISTINE AUROBINDO TABS
    • Romania (RO)
      Betahistina diclorhidrat Aurobindo 8 mg comprimate
    • Malta (MT)
      Betahistine 8 mg tablets
许可日期2014/07/10
最近更新日期2024/08/13
药物ATC编码
    • N07CA01 betahistine
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase